Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells

Comprehensive treatment based on chemotherapy is regarded as the first-line treatment for patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC). However, chemoresistance is common among patients with ESCC. Therefore, there is a need to explore new therapeutic strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: DANG, LIFENG, WEN, FENGBIAO, YANG, YANG, LIU, DONGLEI, WU, KAI, QI, YU, LI, XIANGNAN, ZHAO, JIA, ZHU, DENGYAN, ZHANG, CHUNYANG, ZHAO, SONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020493/
https://www.ncbi.nlm.nih.gov/pubmed/24584782
http://dx.doi.org/10.3892/ijmm.2014.1678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020493/
https://www.ncbi.nlm.nih.gov/pubmed/24584782
http://dx.doi.org/10.3892/ijmm.2014.1678

Ejemplares similares